S
PRQR icon

SignatureFD’s ProQR Therapeutics PRQR Stock Holding History

SignatureFD’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,824
Closed -$15.4K – 3417
2024
Q4 		$15.4K Buy
+5,824
New +$18.5K ﹤0.01% 2195
2022
Q1 		– Sell
-2,027
Closed -$16K – 3285
2021
Q4 		$16K Buy
2,027
+53
+3% +$404 ﹤0.01% 1890
2021
Q3 		$17K Buy
1,974
+1,684
+581% +$11K ﹤0.01% 1834
2021
Q2 		$2K Buy
+290
New +$1.87K ﹤0.01% 2609
2020
Q4 		– Sell
-431
Closed -$2K – 2672
2020
Q3 		$2K Hold
431
– – ﹤0.01% 2269
2020
Q2 		$3K Sell
431
-15
-3% -$81 ﹤0.01% 2010
2020
Q1 		$2K Buy
+446
New +$3.42K ﹤0.01% 1987

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

SignatureFD's PRQR Position: Q1 2025 in Review

SignatureFD sold out of ProQR Therapeutics (PRQR) in Q1 2025, closing a stake of 5,824 shares — an estimated $15.4K sold.

SignatureFD first reported a position in PRQR in Q1 2020 and held it in 7 quarters. The position peaked at $17K in Q3 2021. 65 funds tracked by Wall St. Rank hold PRQR as of Q1 2025.

  • SignatureFD reported no remaining ProQR Therapeutics position as of Q1 2025 after selling out during the quarter.
  • SignatureFD sold 5,824 ProQR Therapeutics shares in Q1 2025, an estimated $15.4K.
  • SignatureFD first reported a position in ProQR Therapeutics in Q1 2020 and held it in 7 quarters.
  • SignatureFD's ProQR Therapeutics position peaked at $17K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.